Perbedaan Organon Pharma Indonesia Tbk. dan Tifico Fiber Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Tifico Fiber Indonesia Tbk. diperdagangkan di Rp800 (kapitalisasi pasar 3,86 T, volume 24 jam 300). Perbedaan utamanya: Tifico Fiber Indonesia Tbk. jauh lebih besar — sekitar 37× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TFCO | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 3,86 T |
Volume | — | 300 |
Lot | — | 3 |
Perputaran | — | 240 rb |
Harga Rata-rata | — | 800 |
Nilai Transaksi | — | 240 rb |
Harga Ekuilibrium Indikatif | — | 800 |
Volume Ekuilibrium Indikatif | — | 300 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Tifico Fiber Indonesia Tbk was established in the Republic of Indonesia under the name PT Teijin Indonesia Fiber Corporation on October 25, 1973. PT Teijin Indonesia Fiber Corporation is founded by two Japanese company: Teijin Limited, and PT Tomen Corporation in 1973. The company has a polyester fiber for textile factory in Tangerang.
Selengkapnya di halaman TFCO →